Suppr超能文献

一项关于女性阿司匹林使用与白内障摘除的前瞻性研究。

A prospective study of aspirin use and cataract extraction in women.

作者信息

Hankinson S E, Seddon J M, Colditz G A, Stampfer M J, Rosner B, Speizer F E, Willett W C

机构信息

Department of Medicine, Channing Laboratory, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115.

出版信息

Arch Ophthalmol. 1993 Apr;111(4):503-8. doi: 10.1001/archopht.1993.01090040095040.

Abstract

We examined the association between aspirin use and the rates of cataract extraction during 8 years of follow-up in a large prospective study of women, the Nurses' Health Study. From 1980 to 1988, we documented 448 senile cataracts diagnosed and extracted during 434,680 person-years of follow-up. While we observed a modest positive association at the higher doses of aspirin use in the age-adjusted analyses, no association was found after accounting for other cataract risk factors (relative risk for > or = 20 years of use, 1.08; 95% confidence interval, 0.84 to 1.39). Among women who consumed seven or more tablets per week for 20 or more years, there was no suggestion of protection; if anything, a nonsignificantly elevated risk was observed (relative risk, 1.31; 95% confidence interval, 0.94 to 1.80). We observed no consistent difference in the relationship between aspirin use and cataract when assessed by age. Overall, we found no evidence to support the substantial reduction in risk of cataract among aspirin users as reported in several previous studies.

摘要

在一项针对女性的大型前瞻性研究——护士健康研究中,我们在8年的随访期内研究了阿司匹林使用与白内障摘除率之间的关联。从1980年到1988年,在434,680人年的随访期内,我们记录了448例确诊并接受摘除的老年性白内障。在年龄调整分析中,虽然我们观察到在较高剂量阿司匹林使用时存在适度的正相关,但在考虑其他白内障危险因素后未发现相关性(使用≥20年的相对风险为1.08;95%置信区间为0.84至1.39)。在每周服用七片或更多片且持续20年或更长时间的女性中,没有保护作用的迹象;如果有任何影响的话,观察到风险有非显著性升高(相对风险为1.31;95%置信区间为0.94至1.80)。按年龄评估时,我们观察到阿司匹林使用与白内障之间的关系没有一致的差异。总体而言,我们没有发现证据支持先前几项研究所报道的阿司匹林使用者白内障风险大幅降低的说法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验